Want to understand how these updates are formatted? Check-out the FAQ.

Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

Arrowhead Pharmaceuticals' Redemplo (plozasiran) gains broader CHMP approval for familial chylomicronemia syndrome without genetic confirmation requirement
Small molecule, metabolic, siRNA, familial chylomicronemia syndrome, APOC3, triglyceride reduction - Read more

EMA recommends approval of Sanofi's tolebrutinib for secondary progressive multiple sclerosis after FDA rejection
Small molecule, neurological, regulatory, strategic - Read more

EU panel recommends Novartis' Itvisma, expanding SMA gene therapy approval beyond infants
Gene therapy, rare disease, regulatory, reformulation - Read more

Thermo Fisher Scientific beats Q1 expectations with 6% revenue growth, raises 2026 guidance
Biopharma services, financial, major transaction, strategic - Read more

🚨 Applications are open for the 2026 Lilly Grand Challenge: Aging Reimagined

🔬 $100K in non-dilutive funding (no strings attached)
🏛️ A 2 day pitch at Lilly HQ in Indianapolis (all expenses paid)
🤝 Direct access to Lilly's scientific and venture teams

This year’s focus: Aging Reimagined — New Health Frontiers (mobility, cognition, immune resilience, regenerative medicine).

If you’re building in this space - or know someone who is - don’t miss this!

📅 Deadline: May 15

👉 Learn More and Apply Here: https://linktr.ee/lillygrandchallenge

Avalyn Pharma plans $200M IPO to develop inhaled treatments for pulmonary fibrosis
Pulmonary fibrosis, small molecule, inhaled drug delivery, clinical-stage - Read more

Astellas Pharma, MSN Pharmaceuticals amend Myrbetriq settlement and license agreement with $75M upfront payment
Licensing deal, small molecule, royalties, commercialization - Read more

Guggenheim predicts Travere Therapeutics' Filspari to hit $3.1B peak sales with explosive FSGS launch
Small molecule, rare disease, revenue impact, competitive - Read more

WCG acquires The Contract Network to streamline AI-driven clinical trial contract and startup workflows
AI technology, clinical trials operations, strategic, major transaction - Read more

Sun Pharma to acquire Organon for $12.5B in largest-ever overseas deal by Indian company
Biosimilar, women's health, strategic, major transaction - Read more

Johnson & Johnson launches 4 prescription drugs on Trump administration's TrumpRx discounted pharmaceutical website
Small molecule, cardiovascular, metabolic disease, cost reduction, strategic - Read more

FDA awards national priority vouchers to Compass Pathways, Transcend Therapeutics, and Usona Institute for psychedelic treatments
Small molecule, neurological, regulatory, strategic - Read more

Novartis' Coartem Baby antimalarial receives WHO prequalification, expanding access for newborns weighing 2-5kg
Small molecule, infectious disease, regulatory, strategic - Read more

Do you offer a biotech/pharma-focused product or service?

Or looking to get investor/analyst interest on your budding start-up?

Considering sponsoring TLDR Biotech to get in-front of an engaged audience of biotech & pharma-focused professionals.

Just reply to this email* or message me on LinkedIn to learn more.

*If you’re reading this on the web version, email [email protected]

Daiichi Sankyo shares fall 10% after earnings delay tied to HER3-DXd supply contract losses
Antibody-drug conjugate, oncology, financial, operational - Read more

CureVac sues Moderna for patent infringement over mRNA technology used in Spikevax COVID-19 vaccine
mRNA vaccine, infectious disease, competitive, financial - Read more

Pfizer plans 100+ layoffs at Ireland's Ringaskiddy plant amid ongoing global cost-cutting campaign
Small molecule, cost reduction, operational, strategic - Read more

Novartis withdraws EU application to broaden Pluvicto's prostate cancer label after regulatory pushback
Radioligand therapy, oncology, competitive, regulatory - Read more

AbbVie's trenibotulinumtoxinE receives FDA complete response letter over manufacturing concerns for glabellar lines
Protein therapy, aesthetics, botulinum toxin, glabellar lines, manufacturing - Read more

Tempero Bio to shut down after serious adverse event halts Phase 2 alcohol use disorder drug TMP-301 development
Small molecule, neurological, mGluR5 modulator, substance use disorder, alcohol use disorder - Read more [Paywall]

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

If you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

And lastly - connect with me on LinkedIn!

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here